{
  "report_rows": [
    {
      "kpi": "Q2 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.10 vs. cons $1.041",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$5.295B vs. cons $5.267B",
      "confidence": "HIGH"
    },
    {
      "kpi": "Q2 PCS revenue",
      "prediction": "MISS",
      "answer": "pred ~$740M vs. cons $750M",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide $4.80-$5.00 vs. cons $4.881",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 FCF",
      "prediction": "LOWER",
      "answer": "guide ~$1.6B vs. cons $1.707B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 organic sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide 3%-4% vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -2.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 maintained FY outlook leaves implied Q4 risk unresolved",
  "day5_confidence": "LOW"
}